File(s) not publicly available
A randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small cell lung cancer (NSCLC)
conference contribution
posted on 2023-05-24, 07:41 authored by Igleslas, J, Cromble, C, Burns, WI, Karapetis, C, Raymond Lowenthal, Kirsten, F, Davidson, JA, Abell, F, Reece, WHH, DeSouza, PNo description available
History
Publication title
European Journal of Cancer AbstractsVolume
1 (5)Editors
European Cancer SocietiesPagination
S235Department/School
Tasmanian School of MedicinePublisher
European Cancer SocietiesPlace of publication
Copenhagen, DenmarkEvent title
ECCO 12 - the European Cancer ConferenceEvent Venue
Copenhagen, DenmarkDate of Event (Start Date)
2003-09-21Date of Event (End Date)
2003-09-25Repository Status
- Restricted
Socio-economic Objectives
Clinical health not elsewhere classifiedUsage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC